Company profile for NEOGAP Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NEOGAP Therapeutics is a privately held biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund and is located at Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden. We are a multidisciplinary team with highly skilled and motivated individuals, bringing together an extensive experience and track record from academia and the pharmaceutical...
NEOGAP Therapeutics is a privately held biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund and is located at Centre for Molecular Medicine at Karolinska Institutet, Stockholm, Sweden. We are a multidisciplinary team with highly skilled and motivated individuals, bringing together an extensive experience and track record from academia and the pharmaceutical industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Center for Molecular Medicine, Karolinska Universitetssjukhuset, Stockholm, 17...
Telephone
Telephone
+46 733 54 21 94
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty